Real-World Costs of Early vs Late OnabotulinumtoxinA Treatment for Post-Stroke Spasticity: A Retrospective Claims Analysis

被引：0
|
作者：
Esquenazi, Alberto [1 ]
List, Cassandra [2 ]
Bloudek, Lisa [3 ]
Brouwer, Elizabeth [3 ]
Lee, Woojung [3 ]
Elsea, David [3 ]
Kang, Ashley [3 ]
Tung, Amy [4 ]
Lee, Jae [4 ]
Bohart, Zach [5 ,6 ]
机构：
[1] MossRehab, Einstein Healthcare Network, Elkins Pk, PA USA
[2] Brooks Rehabil, Jacksonville, FL USA
[3] Curta Inc, Seattle, WA USA
[4] AbbVie, 2525 Dupont Dr, Irvine, CA 92612 USA
[5] Tufts Med Ctr, Boston, MA USA
[6] Brown Univ, Warren Alpert Med Sch, Providence, RI USA
来源：
TOXICON | 2024年 / 237卷
关键词：
OnabotulinumtoxinA; Post-stroke spasticity;
D O I：
10.1016/j.toxicon.2024.107395
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：25 / 26
页数：3
相关论文
共 28 条
  • [1] High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis
    Baricich, Alessio
    Grana, Elisa
    Carda, Stefano
    Santamato, Andrea
    Cisari, Carlo
    Invernizzi, Marco
    JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (09) : 1283 - 1287
  • [2] High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis
    Alessio Baricich
    Elisa Grana
    Stefano Carda
    Andrea Santamato
    Carlo Cisari
    Marco Invernizzi
    Journal of Neural Transmission, 2015, 122 : 1283 - 1287
  • [3] Real-World Retrospective Safety Analysis of OnabotulinumtoxinA for the Concomitant Treatment of Patients With Spasticity and Other Therapeutic Indications
    Mayadev, Angeli
    Ayyoub, Ziyad
    Patel, Atul
    Ifantides, Kim Becker
    Ukah, Ahunna
    Nelson, Mariana
    Battucci, Simona
    Brown, Theodore
    TOXICON, 2024, 237 : 58 - 59
  • [4] Dose Response with OnabotulinumtoxinA for Post-Stroke Spasticity: A Pooled Data Analysis
    Yablon, Stuart A.
    Brin, Mitchell F.
    VanDenburgh, Amanda M.
    Zhou, Jihao
    Garabedian-Ruffalo, Susan M.
    Abu-Shakra, Susan
    Beddingfield, Frederick C., III
    MOVEMENT DISORDERS, 2011, 26 (02) : 209 - 215
  • [5] Real-World Dosing Differences of OnabotulinumtoxinA and AbobotulinumtoxinA in Treatment of Upper Limb Spasticity
    Singh, Ritu
    Zuzek, Aleksej
    Schwartz, Marc
    Nelson, Mariana
    TOXICON, 2022, 214 : S69 - S70
  • [6] Real-world Adherence to Subsequent CGRP mAb Treatment Among Chronic Migraine Patients Initially Treated With OnabotulinumtoxinA: A Retrospective Claims Analysis
    Dong, Yanan
    Gusovsky, Amanda
    Shah, Darshini
    Park, Tae Jin
    Zhao, Changgeng
    TOXICON, 2024, 237 : 22 - 22
  • [7] Real-world differences in dosing and clinical utilization of OnabotulinumtoxinA and AbobotulinumtoxinA in the treatment of upper limb spasticity
    Bohart, Zachary
    Dashtipour, Khashayar
    Kim, Heakyung
    Schwartz, Marc
    Zuzek, Aleks
    Singh, Ritu
    Nelson, Mariana
    TOXICON, 2024, 241
  • [8] A retrospective study to assess resource utilization and costs in patients with post-stroke spasticity in the United Kingdom
    Raluy-Callado, Mireia
    Cox, Andrew
    MacLachlan, Sharon
    Bakheit, Abdel M.
    Moore, A. Peter
    Dinet, Jerome
    Gabriel, Sylvie
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (07) : 1317 - 1324
  • [9] Real-World Persistence and Costs Among Patients With Chronic Migraine Treated With OnabotulinumtoxinA or Calcitonin Gene-Related Peptide Monoclonal Antibodies: A Retrospective Claims Analysis Study
    Schwedt, Todd J.
    Lee, Jae
    Knievel, Kerry
    McVige, Jennifer
    Wang, Weiying
    Wu, Zheng
    Gillard, Patrick
    Shah, Darshini
    Blumenfeld, Andrew M.
    TOXICON, 2022, 214 : S68 - S69
  • [10] Real-World Treatment Utilization and Effectiveness of OnabotulinumtoxinA in Multiple Sclerosis Patients Treated for Spasticity From the ASPIRE Study
    Bandari, Daniel S.
    Mayadev, Angeli
    Sakel, Mohamed
    Esquenazi, Alberto
    Zuzek, Aleksej
    Largent, Joan
    Francisco, Gerard E.
    TOXICON, 2022, 214 : S6 - S6
123